Paula M. Cannon

6.8k citations

79 papers · 4.4k indexed · 2 hit papers · h-index 37

Co-authors: Susan M. Kingsman Alan J. Kingsman W. French Anderson Colin M. Exline Gaetano Romano Joanne C. Griffiths Michael C. Holmes Philip D. Gregory
Topics: HIV Research and Treatment (40 papers)Virus-based gene therapy research (23 papers)CRISPR and Genetic Engineering (20 papers)
Cited by: Virology Infectious Diseases Genetics
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Nature Genetics
Partner nations: United States United Kingdom Spain

In The Last Decade

Paula M. Cannon

76 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A transient three-plasmid expression system for the production of high titer retroviral vectors

1995 612 citations Paula M. Cannon et al. profile →
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo

2010 534 citations Donald B. Kohn, Paula M. Cannon et al. profile →

Peers

Countries citing papers authored by Paula M. Cannon

Since Specialization

Citations

This map shows the geographic impact of Paula M. Cannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula M. Cannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula M. Cannon more than expected).

Fields of papers citing papers by Paula M. Cannon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula M. Cannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula M. Cannon. The network helps show where Paula M. Cannon may publish in the future.

Co-authorship network of co-authors of Paula M. Cannon

This figure shows the co-authorship network connecting the top 25 collaborators of Paula M. Cannon. A scholar is included among the top collaborators of Paula M. Cannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula M. Cannon. Paula M. Cannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Overcoming barriers to commercially pre-viable gene and cell therapies for rare and ultra-rare diseases 2025 ·Molecular Therapy ·(unknown),Paula M. Cannon,Federico Mingozzi,Matthew H. Porteus,Isabelle Rivière,Terence R. Flotte	0
2	Reprogramming human B cells with custom heavy-chain antibodies 2024 ·Nature Biomedical Engineering ·Geoffrey L. Rogers,(unknown),(unknown),Xiaoli Huang,(unknown),(unknown),(unknown),(unknown),Eric J. Kezirian,Paula M. Cannon	4
3	Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides 2023 ·Journal of Virology ·George N. Llewellyn,(unknown),Geoffrey L. Rogers,(unknown),(unknown),Jill Henley,Paula M. Cannon	4
4	SARS-CoV-2 Enters Human Leydig Cells and Affects Testosterone Production In Vitro 2023 ·Cells ·Lu Li,Chantal M. Sottas,(unknown),Yuchang Li,(unknown),Jason Villano,Joseph L. Mankowski,Paula M. Cannon,Vassilios Papadopoulos	7
5	Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes 2021 ·Molecular Therapy — Methods & Clinical Development ·Geoffrey L. Rogers,(unknown),(unknown),Eduardo Seclén,(unknown),Paula M. Cannon	24
6	Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation 2021 ·Journal of Virology ·(unknown),(unknown),Lü Tian,(unknown),(unknown),George N. Llewellyn,Geoffrey L. Rogers,(unknown),Maurice R.G. O’Gorman,Ya‐Wen Chen,Paula M. Cannon	20
7	Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development 2021 ·Human Gene Therapy ·Paula M. Cannon,Aravind Asokan,Agnieszka Czechowicz,Paula T. Hammond,Donald B. Kohn,André Lieber,Punam Malik,Peter Marks,Matthew H. Porteus,Els Verhoeyen,Drew Weissman,Irving L. Weissman,Hans‐Peter Kiem	17
8	Knockdown of Astrocytic Monocarboxylate Transporter 4 in the Motor Cortex Leads to Loss of Dendritic Spines and a Deficit in Motor Learning 2021 ·Molecular Neurobiology ·(unknown),George N. Llewellyn,(unknown),(unknown),Paula M. Cannon,Giselle M. Petzinger,Michael W. Jakowec	13
9	Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing 2020 ·Molecular Therapy ·(unknown),(unknown),(unknown),Matthew E. Thornton,Brendan H. Grubbs,Paula M. Cannon	23
10	Timothy Ray Brown: The Serendipitous Hero of HIV Cure Research 2020 ·AIDS Research and Human Retroviruses ·Thomas J. Hope,Nichole R. Klatt,Jonah B. Sacha,Paula M. Cannon	0
11	Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break 2019 ·Molecular Therapy ·Geoffrey L. Rogers,(unknown),(unknown),Paula M. Cannon	13
12	Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious Diseases 2017 ·Hematology/Oncology Clinics of North America ·Geoffrey L. Rogers,Paula M. Cannon	11
13	Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment 2016 ·AIDS Patient Care and STDs ·Andrew W. Woodham,Joseph G. Skeate,(unknown),Julia R. Taylor,Diane M. Da Silva,Paula M. Cannon,W. Martin Kast	37
14	A Cure for HIV Infection: “Not in My Lifetime” or “Just Around the Corner”? 2016 ·SHILAP Revista de lepidopterología ·Michael M. Lederman,Paula M. Cannon,Judith S. Currier,Carl H. June,Hans‐Peter Kiem,Daniel R. Kuritzkes,Sharon R. Lewin,David M. Margolis,Joseph M. McCune,John W. Mellors,Timothy W. Schacker,Rafick‐Pierre Sékaly,Pablo Tebas,Bruce D. Walker,Daniel C. Douek	29
15	Clinical Applications of Genome Editing to HIV Cure 2016 ·AIDS Patient Care and STDs ·(unknown),Paula M. Cannon	11
16	Pre-clinical Modeling of CCR5 Knockout in Human Hematopoietic Stem Cells by Zinc Finger Nucleases Using Humanized Mice 2013 ·The Journal of Infectious Diseases ·Ursula Hofer,Jill Henley,Colin M. Exline,(unknown),(unknown),Paula M. Cannon	31
17	Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors 2008 ·Gene Therapy ·Christoph Kahl,Paula M. Cannon,Jill Oldenburg,A. F. Tarantal,Donald B. Kohn	12
18	Receptor use by the Whitewater Arroyo virus glycoprotein 2007 ·Virology ·(unknown),Jill Oldenburg,M. FLANAGAN,(unknown),(unknown),Paula M. Cannon	21
19	Identification of Regions in the Moloney Murine Leukemia Virus SU Protein That Tolerate the Insertion of an Integrin-Binding Peptide 2000 ·Virology ·Bonnie Wu,Jianfeng Lü,Timothy K. Gallaher,W. French Anderson,Paula M. Cannon	43
20	Mobilization of plasmid ntp16 by a variety of conjugative plasmids 1988 ·Heredity ·Paula M. Cannon,Peter Strike	1

About Paula M. Cannon

Paula M. Cannon is a scholar working on Virology, Infectious Diseases and Genetics, having authored 79 papers that have together received 4.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (40 papers), Virus-based gene therapy research (23 papers) and CRISPR and Genetic Engineering (20 papers). The work is most often cited by research in Virology (1.6k citations), Infectious Diseases (1.1k citations) and Genetics (1.6k citations). Paula M. Cannon has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Susan M. Kingsman, Alan J. Kingsman, W. French Anderson, Colin M. Exline, Gaetano Romano, Joanne C. Griffiths, Michael C. Holmes, Philip D. Gregory, Jianbin Wang and Jill Oldenburg. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact